ReviewCell & bioscience2025
The multifaceted roles of non-coding RNAs in cell-cell communication in cardiovascular health and disease.
Review in Cell & bioscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Unifying and unique roles of non-coding RNA biomarkers in liver and heart fibrosis.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2026Review
- Effect of the cardiac long non-coding RNA Charme depletion on the maturation and paracrine signaling of resident cardiac fibroblasts.Cell death & disease · 2026Article
- Immuno-inflammatory-metabolic interactions in cardiovascular diseases: a review from basic mechanisms to clinical translation.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Non-coding RNAs are critical regulators of cell-to-cell communication in the cardiovascular system, playing pivotal roles in heart development, function, and disease progression. Among these, extracellular vesicles, RNA-binding proteins, and lipoprotein complexes have emerged as key carriers, facilitating the paracrine-and occasionally endocrine-transfer of non-coding RNAs. While extensive evidence supports the role of microRNAs in mediating communication between cardiomyocytes, fibroblasts, endothelial cells, and immune cells, the involvement of long non-coding RNAs and their carriers in cardiac intercellular signaling remains understudied. This review explores how non-coding RNA carriers protect these molecules from extracellular degradation and ensure targeted delivery to recipient cells, enabling precise modulation of gene expression. Furthermore, we highlight the gaps in understanding the mechanisms of non-coding RNA uptake and their implications, which can be addressed through advanced sequencing technologies, such as single-cell RNA sequencing. These tools provide unparalleled insights into non-coding RNA-mediated communication networks in the heart, shedding light on their roles in maintaining homeostasis and driving disease. Finally, we contrast the well-established microRNA-driven communication mechanisms with the emerging significance of long non-coding RNAs. We also discuss how sequencing advancements transform our understanding of non-coding RNA-based signaling pathways in cardiovascular health and disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.